Pharmacokinetics and safety of ABT-578, a sirolimus (rapamycin) analogue, after single intravenous bolus injection in healthy male volunteers

Clinical Drug Investigation

Volumn 25, Issue 8, 2005, Pages 491-498

  Palaparthy, Rameshraja ^a,b   Pradhan, Rajendra ^a   Chan, Jenny ^a   Wang, Qiang ^a   Ji, Qin ^a   Achari, Ramanuj ^a   Chira, Titus ^a   Schwartz, Lewis B ^a   O'Dea, Robert ^a  

^a ABBOTT LABORATORIES   (United States)

^b Abbott Laboratories Abbott Park ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABT 578; PLACEBO; RAPAMYCIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INJECTION SITE REACTION; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PAIN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 23044446485     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200525080-00001     Document Type: Article

References (20)

1. Ajani AE, Kim HS, Waksman R. Clinical trials of vascular brachytherapy for in-stent restenosis: update. Cardiovasc Radiat Med 2001; 2 (2): 107-13
2. Herzum M, Schaefer JR, Simon B, et al. Restenosis after percutaneous coronary interventions and infection. Herz 2000; 25 (2): 91-4
3. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331 (8): 489-95
4. Erbel R, Haude M, Hopp HW, et al. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. N Engl J Med 1998; 339 (23): 1672-8
5. Mintz GS, Hoffmann R, Mehran R, et al. In-stent restenosis: the Washington Hospital Center experience. Am J Cardiol 1998; 81 (7A): 7E-13E
6. Groth CG, Backman L, Morales JM, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 1999; 67 (7): 1036-42
7. Casterella PJ, Teirstein PS. Prevention of coronary restenosis. Cardiol Rev 1999; 7 (4): 219-31
8. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circula-tion 2001; 103 (2): 192-5
9. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104 (17): 2007-11
10. Sousa JE, Costa MA, Sousa AG, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003; 107 (3): 381-3
11. Brattstrom C, Sawe J, Jansson B, et al. Pharmacokinetics and safety of single oral doses of sirolimus (rapamycin) in healthy male volunteers. Ther Drug Monit 2000; 22 (5): 537-44
12. Yatscoff RW. Pharmacokinetics of rapamycin. Transplant Proc 1996; 28 (2): 970-3
13. Gallant-Haidner HL, Trepanier DJ, Freitag DG, et al. Pharmacokinetics and metabolism of sirolimus. Ther Drug Monit 2000; 22 (1): 31-5
14. Schwartz RS, Burke SE, Cromack K, et al. Marked neointimal inhibition from a drug eluting stent: effects of local ABT-578 in the porcine coronary model [abstract]. Circulation 2002; 106 Suppl. II: 448
15. Buellesfeld L, Grube E. ABT-578-eluting stents: the promising successor of sirolimus- and paclitaxel-eluting stent concepts? Herz 2004; 29 (2): 167-70
16. Salu KJ, Bosmans JM, Bult H, et al. Drug-eluting stents: a new treatment in the prevention of restenosis. Part I: experimental studies. Acta Cardiol 2004; 59 (1): 51-61
17. Salu KJ, Bosmans JM, Bult H, et al. Drug-eluting stents: a new treatment in the prevention of restenosis. Part II: clinical studies. Acta Cardiol 2004; 59 (2): 165-77
18. Ji QC, Todd Reimer M, El-Shourbagy TA. 96-well liquid-liquid extraction liquid chromatography-tandem mass spectrometry method for the quantitative determination of ABT-578 in human blood samples. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 805 (1): 67-75
19. Zimmerman JJ, Kahan BD. Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration. J Clin Pharmacol 1997; 37 (5): 405-15
20. Kahan BD. Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus. Ther Drug Monit 2002; 24 (1): 47-52